Please use this identifier to cite or link to this item:
標題: Protocadherin γA-12(PCDH21)基因表現於乳癌細胞株MDA-MB-231之腫瘤抑制相關功能性分析
The tumor-suppressor functional studies of protocadherin γA -12 (PCDH21) gene in breast cancer cell line MDA-MB-231
作者: 林憲儀
Lin, Hsien-Yi
關鍵字: cadherin
tumor suppressor gene
cell proliferation
wound-healing assay
cell invasion
出版社: 生命科學系所
引用: 江敏瑜。2005。PCDH21 基因於乳癌檢體及乳癌細胞株之基因甲基化修飾調控及其功能性分析。中興大學生命科學系碩士論文。 Anastasiadis, P. Z., S. Y. Moon, M. A. Thoreson, D. J. Mariner, H. C. Crawford, Y. Zheng, and A. B. Reynolds. 2000. Inhibition of RhoA by p120 catenin. Nat. Cell Biol. 2:637-644. Brekelmans, C. T., C. Seynaeve, C. C. Bartels, M. M. Tilanus-Linthorst, E. J. Meijers- Heijboer , C. M. Crepin, A. A. van Geel, M. Menke, L. C. Verhoog, A. van den Ouweland, I. M. Obdeijn, and J. G. Klijn. 2001. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J. Clin. Oncol. 19: 924-930. Birchmeier, C., W. Birchmeier, and B. Brand-Saberi. 1996. Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 156: 217–226. Birchmeier, W., and J. Behrens. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1198: 11-26. Bracke, M. E., F. M. Van Roy, and M. M. Mareel. 1996. The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol. 213: 123–161. Bradley, R. S., A. Espeseth, and C. Kintner. 1998. NF-protocadherin, a novel member of the cadherin superfamily, is required for Xenopus ectodermal differentiation. Curr. Biol. 8: 325-334. Caveda, L., I. Martìn-Padura, P. Navarro, F. Breviario, M. Corada, D. Gulino, M. G. Lampugnani, and E. Dejana. 1996. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J. Clin. Invest.15: 886-893. Casey, G. 1997. The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9: 88–93. Chen, C. M., H. L. Chen, T. H. Hsiau, A. H. Hsiau, H. Shi, G. J. Brock, S. H. Wei, C.W.Caldwell, P. S. Yan, and T. H. Huang. 2003. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes. Am J Pathol. 163: 37-45. Chen, H., N. Paradies, M. Fedor-Chaiken, and R. Brackenbury. 1997. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci. 110: 345-356. Comings, D. E. 1973. A general theory of carcinogenesis. Proc. Natl. Acad. Sci. USA.70: 3324-3328. Conacci-Sorrell, M., I. Simcha, T. Ben-Yedidia, J. Blechman, P. Savagner, and A. Ben- Ze''ev. 2003. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J. Cell Biol. 163: 847-857. Couch, F. J., M. L. DeShano, M. A. Blackwood, K. Calzone, J. Stopfer, L. Campeau, A. Ganguly, T. Rebbeck, and B. L. Weber. 1997. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336: 1409-1415. Davis, M. A., R. C. Ireton, and A. B. Reynolds. 2003. A core function for p120-catenin in cadherin turnover. J. Cell Biol. 163: 525–534. Dixon, J. M., D. L. Page, T. J. Anderson, D. Lee, R. A. Elton, H. J. Stewart, and A. P. Forrest. 1985. Long-term survivors after breast cancer. Br. J. Surg. 72: 445-448. Dixon, J. M. 1995. Surgery and radiotherapy for early breast cancer. B M J. 311: 1515-1516. Eger, A., A. Stockinger, B. Schaffhauser, H. Beug, and R. Foisner. 2000. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of ß-catenin and upregulation of ß-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell. Biol 148:173–187. Fagotto, F., N. Funayama, U. Gluck, and B. M. Gumbiner. 1996. Binding of cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus. J. Cell Biol. 132: 1105-1114. Fang, X., H. Ji, S. W. Wan Kim, J. I. Park, T. G. Vaught, P. Z. Anastasiadis, M. Ciesiolka, and P. D. McCrea. 2004. Vertebrate development requires ARVCF and p120 catenins and their interplay with RhoA and Rac. J. Cell Biol. 165: 87-98. Fedor-Chaiken, M., T. E. Meigs, D. D. Kaplan, and R. Brackenbury. 2003. Two regions of cadherin cytoplasmic domains are involved in suppressing motility of a mammary carcinoma cell line. J. Biol. Chem. 278: 52371-5237. Francke, U., and F. Kung. 1976. Sporadic bilateral retinoblastoma and 13q-deletion. Med. Pediatr. Oncol. 2: 379–385. Frank, M., and R. Kemler. 2002. Protocadherins. Curr. Opin. Cell Biol. 14: 557–562. Frixen, U. H., J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. Löchner, and W. Birchmeier 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:173-185. Fukata, M., and K. Kaibuchi. 2001. Rho-family GTPases in cadherin-mediated cell- cell adhesion. Nat. Rev. Mol. Cell Biol. 2: 887-897. Gallin, W. J., G. M. Edelman, and B. A. Cunningham. 1983. Characterization of L-CAM, a major cell adhesion molecule from embryonic liver cells. Proc Natl. Acad. Sci. USA. 80: 1038-1042. Grosheva, I., M. Shtutman, M. Elbaum, and A. D.Bershadsky. 2001. p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion. J. Cell Sci. 114: 695-707. Gumbiner, B. M. 2005. Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 6: 622-634. Haas, I. G., M. Frank, N. Veron, and R. Kemler. 2005. Presenilin-dependent processing and nuclear function of γ-protocadherins. J. Biol. Chem. 280: 9313–9319. Hambsch, B., V. Grinevich, P. H. Seeburg, and M. K. Schwarz. 2005. γ-Protocadherins, presenilin-mediated release of C-terminal fragment promotes locus expression. J. Biol. Chem. 280: 15888–15897. Harris, H., O. J. Miller, G. Klein, P. Worst, and T. Tachibana. 1969. Suppression of malignancy by cell fusion. Nature 223: 363–368. Hatta, K., S. Takagi, H. Fujisawa, and M. Takeichi. 1987. Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev. Biol. 120: 215-217. Hazan, R. B., G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson. 2000. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148: 779-790. Hazan, R. B., R. Qiao, R. Keren, I. Badano, and K. Suyama. 2004. Cadherin switch in tumor progression. Ann. N. Y. Acad. Sci. 1014: 155-163. Heasman, J., A. Crawford, K. Goldstone, P. Garner-Hamrick, B. Gumbiner, P. McCrea, C. Kintner, C. Y. Noro, and C. Wylie. 1994. Overexpression of cadherins and underexpression of β-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 79: 791-803. Heyers, D., H. Luksch, and C. Redies. 2004. Selective synaptic cadherin expression by traced neurons of the chicken visual system. Neuroscience 127: 901-912. Homayouni, R., D.S. Rice, and T. Curran. 2001. Disabled-1 interacts with a novel developmentally regulated protocadherin. Biochem. Biophy. Res. Commun. 289:539-547. Hengel, J. V., P. Vanhoenacker, K. Staes, and F. van Roy. 1999. Nuclear localization of the p120ctn Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc. Natl. Acad. Sci. USA. 96: 7980-7985. Imoto, I., H. Izumi, S. Yokoi, H. Hosoda, T. Shibata, F. Hosoda, M. Ohki, S. Hirohashi, and J. Inazawa. 2006. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res. 66: 4617-4626. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304–6311. Kim, S. H., A. Yamamoto, T. Bouwmeester, E. Agius, and E. M. De Robertis. 1998. The role of paraxial protocadherin in selective adhesion and cell movements of the mesoderm during Xenopus gastrulation. Development 125: 4681–4690. Kiss, A., and S. Mervn. 2001. Effect of sex and gender on psychosocial aspects of prostate and breast cancer. Br. Med. J. 323: 1055-1058. Knudson, A. G. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 68: 820–823. Knudson, A. G. 1973. Mutation and human cancer. Adv. Cancer Res. 17: 317–352. Knudson, A. G., A. T. Meadows, W. W. Nichols, and R. Hill. 1976. Chromosomal deletion and retinoblastoma. N. Engl. J. Med. 295: 1120–1123. Kohmura, N., K. Senzaki, S. Hamada, N. Kai, R. Yasuda, M. Watanabe, H. Ishii, M. Yasuda, M. Mishina, and T. Yagi. 1998. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron 20: 1137-1151. Kuroda, S., M. Fukata, M. Nakagawa, K. Fujii, T. Nakamura, T. Ookubo, I. Izawa, T. Nagase, N. Nomura, H. Tani, I. Shoji, Y. Matsuura, S. Yonehara, and K. Kaibuchi. 1998. Role of IQGAP1, a target of the small GTPases CDC42 and Rac1, in regulation of E-cadherin-mediated cell–cell adhesion. Science 281: 832–835. Kuroda, H., M. Inui, K. Sugimoto, T. Hayata, and M. Asashima. 2002. Axial Protocadherin is a mediator of prenotochord cell sorting in Xenopus. Dev. Biol. 244:267-277. Larue, L., M. Ohsugi, J. Hirchenhain, and R. Kemler. 1994. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA. 91: 8263-8267. Levenberg, S., A.Yarden, Z. Kam, and B. Geiger. 1999. p27 is involved in N- cadherin- mediated contact inhibition of cell growth and S-phase entry. Oncogene 18: 869-876. Magg, T., D. Schreiner, G. P. Solis, E. G. Bade, and H. W. Hofer. 2005. Processing of the human protocadherin Fat1 and translocation of its cytoplasmic domain to the nucleus. Exp. Cell Res. 307: 100–108. Mahoney, P. A., U. Weber, P. Onofrechuk, H. Biessmann, P. J. Bryant, and C. S. Goodman. 1991. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 67: 853-868. Matsunaga, M., K. Hatta, A. Nagafuchi, and T. Takeichi. 1988. Guidance of optic nerve fibres by N-cadherin adhesion molecules. Nature 334: 62–64. Matsuyoshi, N., and S. Imamura.1997. Multiple cadherins are expressed in human fibroblasts. Biochem. Biophys. Res. Commun. 235: 355-358. Miyatani, S., K. Shimamura, M. Hatta, A. Nagafuchi, A. Nose, M. Matsunaga, K. Hatta, and M. Takeichi. 1989. Neural cadherin: role in selective cell-cell adhesion. Science 245: 631–635. Moeller, M. J., A. Soofi, G. S. Braun, X. Li, C. Watzl, W. Kriz, and L. B. Holzman. 2004.Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J. 23: 3769–3779. Nieman, M. T., R. S. Prudoff, K. R. Johnson, and M. J. Wheelock. 1999. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147: 631-644. Niewiadomska, P., D. Godt, and U. Tepass. 1999. DE-Cadherin is required for intercellular motility during Drosophila oogenesis. J. Cell Biol. 144: 533 -547. Noel, B., B. Quack, and M. O. Rethore. 1976. Partial deletions and trisomies of chromosome 13: mapping of bands associated with particular malformations. Clin Genet. 9: 593–602. Noren, N. K., B. P. Liu, K. Burridge, and B. Kreft. 2000. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 150: 567-580. Nose, A., A. Nagafuchi, and M. Takeichi. 1987. Isolation of placental cadherin cDNA: identification of a novel gene family of cell-cell adhesion molecules. EMBO J. 6:3655–3661. Okazaki, N., N. Takahashi, S. Kojima, Y. Masuho, and H. Koga. 2002. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23: 1139-1148. Orsulic, S., O. Huber, H. Aberle, S. Arnold, and R. Kemler. 1999. E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation. J. Cell Sci. 112:1237–1245. Peinado, H., F. Portillo, and A. Cano. 2004. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48: 365-375. Perrais, M., X. Chen, M. Perez-Moreno, and B. M. Gumbiner. 2007. E-Cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 18: 2013-2025. Peyriéras, N., F. Hyafil, D. Louvard, H. L. Ploegh, and F. Jacob. 1983. Uvomorulin: a nonintegral membrane protein of early mouse embryo. Proc. Natl. Acad. Sci. USA. 80: 6274-6277. Pishvaian, M. J., C. M. Feltes, P. Thompson, M. J. Bussemakers, J. A. Schalken, and S. W. Byers. 1999. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res: 947-952. Price, S. R., N. V. De Marco Garcia, B. Ranscht, and T. M. Jessell. 2002. Regulation of motor neuron pool sorting by differential expression of type II cadherins. Cell 109: 205–216. Rashid, D., K. Newell, L. Shama, and R. Brasley. 2006. A requirement for NF- protocadherin and TAF1/Set in cell adhesion and neural tube formation. Dev. Biol. 291:170-181. Riethmacher, D., V. Brinkmann, and C. Birchmeier. 1995. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. USA. 92: 855-859. Sadot, E., I. Simcha, M. Shtutman, A. Ben-Ze''ev, and B. Geiger. 1998. Inhibition of β-catenin-mediated transactivation by cadherin derivatives. Proc. Natl. Acad. Sci.USA. 95: 15339-15344. Sano, K., H. Tanihara, R. L. Heimark, S. Obata, M. Davidson, T. St. John, S. Taketani, and S. Suzuki. 1993. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 12: 2249–2256. Senzaki, K., M. Ogawa, and T. Yagi. 1999. Proteins of the CNR family are multiple receptors for reelin. Cell 99: 635-647. Sherr, C. J. 2004. Principles of tumor suppression. Cell 116: 235-246. Shibamoto, S., M. Hayakawa, K. Takeuchi, T. Hori, N. Oku, K. Miyazawa, N. Kitamura, M. Takeichi, and F. Ito. 1994. Tyrosine phosphorylation of ß-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes. Commun. 1: 295 -305. Siitonen, S. M, J. T. Kononen, H. J. Helin, I. S. Rantala, K. A. Holli, and J. J. Isola. 1996. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105: 394-402. Simcha, I., M. Shtutman, D. Salomon, J. Zhurinsky, E. Sadot, B. Geiger, and A. Ben- Ze''ev. 1998. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J. Cell Biol. 141: 1433–1448. Sommers, C. L., E. W. Thompson, J. A. Torri, R. Kemler, E. P. Gelmann, and S. W. Byers. 1991. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth. Differ. 2: 365-372. Suzuki, S. T. 2000. Recent progress in protocadherin research . Exp. Cell Res. 261: 13–18. Stanbridge, E. J. 1976. Suppression of malignancy in human cells. Nature 260: 17–20. St. Croix, B., C. Sheehan, J. W. Rak, V. A. Flørenes, J. M. Slingerland, and R. S. Kerbel. 1998. E-cadherin-depedent growth suppression is mediated by the cyclin- dependent kinase inhibitor p27KIPI. J. Cell Biol. 142: 557-571. Stockinger, A., A. Eger, J. Wolf, H. Beug, and R. Foisner. 2001. E-cadherin regulates cell growth by modulating proliferation-dependent ß-catenin transcriptionalactivity. J. Cell Biol. 154: 1185-1196. Takeichi, M. 1993. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5: 806-811. Thiery, J. P, and J. P. Sleeman. 2006. Complex networks orchestrate epithelial- mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7: 131-142. Uchida, N., Y. Honjo, K. R. Johnson, M. J. Wheelock, and M. Takeichi. 1996. The catenin/cadherin adhesion system is localized in synaptic junctions bordering transmitter release zones. J. Cell Biol. 135: 767 -779. Unterseher F., J. A. Hefele, K. Giehl, E. M. De Robertis, D. Wedlich and A. Schambony. 2004. Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK . EMBO J. 23: 3259–3269. Waha, A., S. Güntner, T. H. Huang, P. S. Yan, B. Arslan, T. Pietsch, O. D. Wiestler, and A. Waha. 2005. Epigenetic silencing of the protocadherin family member PCDH-γ-A11 in astrocytomas. Neoplasia 7: 193-199. Wang, F., R. K. Hansen, D. Radisky, T. Yoneda, M. H. Barcellos-Hoff, O. W. Petersen, E. A. Turley, and M. J. Bissell. 2002. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J. Natl. Cancer Inst. 94: 1494-1503. Weiner, J. A., X. Wang, J. C. Tapia, and J. R. Sanes. 2005. Gamma protocadherins are required for synaptic development in the spinal cord. Proc. Natl. Acad. Sci. USA. 102: 8-14. Wolverton, T., and M. Lalande. 2001. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 76:66-72. Wong, A. S., and B. M. Gumbiner. 2003. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol. 161: 1191-1203. Wu, Q., and T. Maniatis. 1999. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97: 779-790. Wu, Q., and T. Maniatis. 2000. Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. Proc. Natl. Acad. Sci. USA. 97: 3124-3129. Yanagisawa, M., and P. Z. Anastasiadis. 2006. p120 catenin is essential for mesenchymal cadherin–mediated regulation of cell motility and invasiveness. J. Cell Biol. 174: 1087-1096. Ying, J., H. Li, T. J. Seng, C. Langford, G. Srivastava, S. W. Tsao, T. Putti, P. Murray, A. T. C Chan, and Q. Tao. 2006. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080. Yoshida, K., M. Watanabe, H. Kato, A. Dutta, and S.Sugano. 1999. BH-protocadherin-c, a member of the cadherin superfamily, interacts with protein phosphatase 1 alpha through its intracellular domain. FEBS Let. 460: 93-98. Electronic Resources: Statistic of Cause of Death, Department of Health, Executive Yuan, Taiwan, R.O.C., August 2006. (Web site: Mature female breast tissue structure and breast cancer development. (; illustrations courtesy of breast cancer. Org) Cell invasion camber assay. (http://www.
摘要: 鈣黏附蛋白分子 (cadherins)在細胞與細胞之間扮演著細胞吸附作用之重要角色。同時鈣黏附蛋白也調控著細胞型態、細胞接觸型抑制,以及在腫瘤演進過程中扮演訊息傳遞的功能。至今有至少80多個鈣黏附蛋白家族成員被發現,包含典型鈣黏附蛋白分子 (classical cadherins)、橋粒鈣黏附蛋白 (desmosomal cadherins)、Fat-like 鈣黏附蛋白 ( Fat-like cadherins),以及原鈣黏附蛋白 (protocadherin)等。過去十年來的研究,大約有超過60多個protocaddherins 成員被鑑定出,同時protocaddherins也是組成鈣黏附蛋白家族成員的最龐大子群。迄今,關於protocaddherins的許多研究均是看重關於參與中樞神經系統發育的功能,而在癌症研究,該基因於腫瘤細胞中所扮演的功能仍是非常少被了解。在先前的研究中,本實驗室發現在具有腫瘤轉移能力的MDA-MB-231 乳癌細胞株中 protocadherin γA-12(PCDH21) 表現量低於不具轉移能力的MCF7乳癌細胞株,同時PCDH21的基因表現受到DNA甲基化的調控。所以為了探究PCDH21 於乳癌細胞中扮演的功能性角色,我們將PCDH21基因大量表現於MDA-MB-231細胞株。於細胞體外的研究分析裡,我們分別檢測PCDH21的表現在乳癌細胞中的細胞增生、細胞移動、細胞侵犯,以及形成細胞群落的能力。首先,於細胞的形態與細胞生長試驗裡,我們發現大量表現PCDH21的MDA-MB-231細胞株能轉變成上皮細胞的形態,同時在這些轉染的MDA-MB-231細胞,其細胞生長的情況也受到抑制。在傷口癒合的實驗裡,我們發現大量轉染表現PCDH21的MDA-MB-231,其細胞移動的能力比起未轉染的MDA-MB-231來得慢。此外,大量轉染表現PCDH21的MDA-MB-231,其細胞侵犯能力與在軟瓊膠 (Soft agar)形成細胞群落的能力也受到抑制。我們進一步將上述的乳癌細胞株以皮下注射的方式施打於 BALB/cAnN.Cg-Foxn1nu/CrlNarl裸鼠的乳腺組織附近之下腹位置,發現在注射施打具有PCDH21表現的MDA-MB-231,其裸鼠體內形成腫瘤的大小明顯小於未轉染的 MDA-MB-231 細胞。所以從上述的實驗結果證實,PCDH21的大量表現能抑制MDA-MB-231乳癌細胞的增生、移動、侵犯,以及形成細胞群落的能力。此外,在裸鼠活體的動物模式裡,PCDH21的大量表現也抑制了MDA-MB-231腫瘤生成的能力。總結本研究之結果,我們首次發現PCDH21於乳癌細胞中扮演著腫瘤抑制的功能性角色,同時該基因之腫瘤抑制於乳癌癌症演進上也相當地重要。
Cadherins play an important role in the cell-cell adhesion between adjacent cells. Meanwhile, cadherins also mediate cell morphology, contact inhibition, and signal transduction during tumorigenesis. There are at least 80 members of the cadherin superfamily in mammalians including classic cadherins, desmosomal cadherins, Fat like cadherins, and protocadherins. Over the past ten years, more than 60 members of protocadherins have been identified and constituted the largest subgroup in the cadherin superfamily. Up to now, many research reported that protocadherins are involved in the development of the central nervous system, but its cell functions in tumor cells of cancer research are poorly understood. In the previous study, we found that metastatic breast cancer cell line MDA-MB-231 expressed a lower level of PCDH21 (protocadherin γA-12) than nonmetastatic breat cancer cell line MCF7 in our lab. Addtionally, PCDH21 gene expression was regulated by DNA methylation. To investigate the functions of PCDH21 expressed in breast cells, we overexpressed the PCDH21 gene in the breast cancer cell line MDA-MB-231. In in vitro study, we examined the physiologic effects of PCDH21 on cell proliferation, cell migration, cell invasion and clonogenicity of breast cancer cell lines. In the cell morphology and cell proliferation assays, we found that overexpression of PCDH21 in the MDA-MB-231 changed cells into epithelial- type morphology. Addtionally, the cell proliferation of transfected MDA-MB-231 was suppressed. In the wound-healing assay, we found that overexpression of PCDH21 in the MDA-MB-231 was slower motility than the control of untransfected MDA-MB-231. Moreover, cell invasion and colony formation in soft agar culture were suppressed after overexpression of PCDH21 in the MDA-MB-231 cells. Furthermore, the cells has been injected subcutaneously into the abdominal region around the mammary site of BALB/cAnN.Cg-Foxn1nu/CrlNarl nude mice. We observed that the nude mice which were injected the PCDH21- overexpressed MDA-MB-231 (No.5 and No.6 clones) had smaller tumor size than those were injected the untransfected MDA-MB-231 cells. Among these studies, our results suggest that exogenous expression of PCDH21 suppressed the tumor cell growth, migration, invasion, and colony formation in MDA-MB-231 cells. Moreover, overexpression of PCDH21 also inhibited tumor formation of MDA-MB-231 in the nude mice model. Therefore, among our study, we first found that PCDH21 may play tumor suppressor roles in breast cells, and its role is critical and involved in the breast cancer tumorigenesis.
其他識別: U0005-2008200711072900
Appears in Collections:生命科學系所



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.